1. Erratum to: Characterization and pathogenesis of aerosolized eastern equine encephalitis in the common marmoset (Callithrix jacchus)
- Author
-
Porter, Aimee I., Erwin-Cohen, Rebecca A., Twenhafel, Nancy, Chance, Taylor, Yee, Steven B., Kern, Steven J., Norwood, David, Hartman, Laurie J., Parker, Michael D., Glass, Pamela J., and DaSilva, Luis
- Subjects
Aerosols ,Male ,Immunity ,Brain ,Callithrix ,Viral Plaque Assay ,Encephalomyelitis, Eastern Equine ,Viral Load ,Kidney ,Immunohistochemistry ,Survival Analysis ,Lethal Dose 50 ,Disease Models, Animal ,Infectious Diseases ,Liver ,Virology ,Animals ,Encephalitis Virus, Eastern Equine ,RNA, Viral ,Female ,Lymph Nodes ,Erratum ,Blood Chemical Analysis - Abstract
Licensed antiviral therapeutics and vaccines to protect against eastern equine encephalitis virus (EEEV) in humans currently do not exist. Animal models that faithfully recapitulate the clinical characteristics of human EEEV encephalitic disease, including fever, drowsiness, anorexia, and neurological signs such as seizures, are needed to satisfy requirements of the Food and Drug Administration (FDA) for clinical product licensing under the Animal Rule.In an effort to meet this requirement, we estimated the median lethal dose and described the pathogenesis of aerosolized EEEV in the common marmoset (Callithrix jacchus). Five marmosets were exposed to aerosolized EEEV FL93-939 in doses ranging from 2.4 × 10The median lethal dose was estimated to be 2.05 × 10We have estimated the medial lethal dose of aerosolized EEEV and described the pathology of clinical disease in the marmoset model. The results demonstrate that the marmoset is an animal model suitable for emulation of human EEEV disease in the development of medical countermeasures.
- Published
- 2017
- Full Text
- View/download PDF